Search research articles
Contact Us
Filters
Showing results (11-20 of 228) with videos related to
Page
of 23
Sort By:
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Are we making progress in GVHD prophylaxis and treatment?
Steven Z Pavletic, Daniel H Fowler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way?
Hillard M Lazarus, Steven Z Pavletic
Nature Clinical Practice. Rheumatology
|
February 21, 2008
Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease
Nikolay P Nikolov, Steven Z Pavletic
Best Practice & Research. Clinical Rheumatology
|
September 10, 2005
The role of immune ablation and stem cell transplantation in severe SLE
Steven Z Pavletic, Gabor G Illei
Blood Advances
|
November 15, 2024
A contemporary downtrend in chronic GVHD?
Najla El Jurdi, Steven Z Pavletic
Blood
|
March 20, 2025
LSS-Skin Sclerosis: key addition to cGVHD assessments
Najla El Jurdi, Steven Z Pavletic
Frontiers in Immunology
|
September 28, 2020
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
Nataliya Prokopenko Buxbaum, Steven Z Pavletic
Blood
|
June 27, 2015
Syk and tired of current chronic GVHD therapies
Daniel H Fowler, Steven Z Pavletic
Haematologica
|
May 26, 2022
Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?
Steven Z Pavletic, Kirk R Schultz
Best Practice & Research. Clinical Haematology
|
August 11, 2004
Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease
Christopher N Bredeson, Steven Z Pavletic
Page
of 23
Search research articles
Search
Showing results (11-20 of 228) with videos related to
Sort By:
Page
of 23
Hematology. American Society of Hematology. Education Program
|
December 13, 2012
Are we making progress in GVHD prophylaxis and treatment?
Steven Z Pavletic, Daniel H Fowler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 13, 2016
Umbilical Cord Blood-Derived Mesenchymal Stromal Cells for Reducing Chronic Graft-Versus-Host Disease After Haploidentical Transplantation: Just Another Labor-Intensive Strategy, or Showing the Way?
Hillard M Lazarus, Steven Z Pavletic
Nature Clinical Practice. Rheumatology
|
February 21, 2008
Technology Insight: hematopoietic stem cell transplantation for systemic rheumatic disease
Nikolay P Nikolov, Steven Z Pavletic
Best Practice & Research. Clinical Rheumatology
|
September 10, 2005
The role of immune ablation and stem cell transplantation in severe SLE
Steven Z Pavletic, Gabor G Illei
Blood Advances
|
November 15, 2024
A contemporary downtrend in chronic GVHD?
Najla El Jurdi, Steven Z Pavletic
Blood
|
March 20, 2025
LSS-Skin Sclerosis: key addition to cGVHD assessments
Najla El Jurdi, Steven Z Pavletic
Frontiers in Immunology
|
September 28, 2020
Autoimmunity Following Allogeneic Hematopoietic Stem Cell Transplantation
Nataliya Prokopenko Buxbaum, Steven Z Pavletic
Blood
|
June 27, 2015
Syk and tired of current chronic GVHD therapies
Daniel H Fowler, Steven Z Pavletic
Haematologica
|
May 26, 2022
Durable discontinuation of systemic therapy for chronic graft-<i>versus</i>-host disease: myth or reality?
Steven Z Pavletic, Kirk R Schultz
Best Practice & Research. Clinical Haematology
|
August 11, 2004
Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease
Christopher N Bredeson, Steven Z Pavletic
Page
of 23